170 related articles for article (PubMed ID: 26457734)
1. Measurement of serum prostate cancer markers using a nanopore thin film based optofluidic chip.
Alzghoul S; Hailat M; Zivanovic S; Que L; Shah GV
Biosens Bioelectron; 2016 Mar; 77():491-8. PubMed ID: 26457734
[TBL] [Abstract][Full Text] [Related]
2. Silver nanoprism etching-based plasmonic ELISA for the high sensitive detection of prostate-specific antigen.
Liang J; Yao C; Li X; Wu Z; Huang C; Fu Q; Lan C; Cao D; Tang Y
Biosens Bioelectron; 2015 Jul; 69():128-34. PubMed ID: 25721976
[TBL] [Abstract][Full Text] [Related]
3. Ultrasensitive electrochemical immunosensor for PSA biomarker detection in prostate cancer cells using gold nanoparticles/PAMAM dendrimer loaded with enzyme linked aptamer as integrated triple signal amplification strategy.
Kavosi B; Salimi A; Hallaj R; Moradi F
Biosens Bioelectron; 2015 Dec; 74():915-23. PubMed ID: 26257183
[TBL] [Abstract][Full Text] [Related]
4. One-step assay for optical prostate specific antigen detection using magnetically engineered responsive thin film.
Esseghaier C; Suaifan GA; Ng A; Zourob M
J Biomed Nanotechnol; 2014 Jun; 10(6):1123-9. PubMed ID: 24749406
[TBL] [Abstract][Full Text] [Related]
5. SERS-Based Pump-Free Microfluidic Chip for Highly Sensitive Immunoassay of Prostate-Specific Antigen Biomarkers.
Gao R; Lv Z; Mao Y; Yu L; Bi X; Xu S; Cui J; Wu Y
ACS Sens; 2019 Apr; 4(4):938-943. PubMed ID: 30864786
[TBL] [Abstract][Full Text] [Related]
6. High-sensitivity immunoassay with surface plasmon field-enhanced fluorescence spectroscopy using a plastic sensor chip: application to quantitative analysis of total prostate-specific antigen and GalNAcβ1-4GlcNAc-linked prostate-specific antigen for prostate cancer diagnosis.
Kaya T; Kaneko T; Kojima S; Nakamura Y; Ide Y; Ishida K; Suda Y; Yamashita K
Anal Chem; 2015 Feb; 87(3):1797-803. PubMed ID: 25546230
[TBL] [Abstract][Full Text] [Related]
7. Prostate specific antigen detection in patient sera by fluorescence-free BioCD protein array.
Wang X; Zhao M; Nolte DD; Ratliff TL
Biosens Bioelectron; 2011 Jan; 26(5):1871-5. PubMed ID: 20236816
[TBL] [Abstract][Full Text] [Related]
8. Prostatic specific antigen and bone scan in the diagnosis and follow-up of prostate cancer. Can diagnostic significance of PSA be increased?
Bantis A; Grammaticos P
Hell J Nucl Med; 2012; 15(3):241-6. PubMed ID: 23227460
[TBL] [Abstract][Full Text] [Related]
9. Portable smartphone quantitation of prostate specific antigen (PSA) in a fluoropolymer microfluidic device.
Barbosa AI; Gehlot P; Sidapra K; Edwards AD; Reis NM
Biosens Bioelectron; 2015 Aug; 70():5-14. PubMed ID: 25775968
[TBL] [Abstract][Full Text] [Related]
10. Multiple biomarkers biosensor with just-in-time functionalization: Application to prostate cancer detection.
Parra-Cabrera C; Samitier J; Homs-Corbera A
Biosens Bioelectron; 2016 Mar; 77():1192-200. PubMed ID: 26590517
[TBL] [Abstract][Full Text] [Related]
11. Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml.
Ornstein DK; Rayford W; Fusaro VA; Conrads TP; Ross SJ; Hitt BA; Wiggins WW; Veenstra TD; Liotta LA; Petricoin EF
J Urol; 2004 Oct; 172(4 Pt 1):1302-5. PubMed ID: 15371828
[TBL] [Abstract][Full Text] [Related]
12. Urchin-like (gold core)@(platinum shell) nanohybrids: A highly efficient peroxidase-mimetic system for in situ amplified colorimetric immunoassay.
Gao Z; Xu M; Lu M; Chen G; Tang D
Biosens Bioelectron; 2015 Aug; 70():194-201. PubMed ID: 25814409
[TBL] [Abstract][Full Text] [Related]
13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
14. Determination of the percentage of free prostate-specific antigen helps to avoid unnecessary biopsies in men with normal rectal examinations and total prostate-specific antigen of 4-10 ng/ml.
Martínez-Piñeiro L; Tabernero A; Contreras T; Madero R; Lozano D; López-Tello J; Alonso-Dorrego JM; Picazo ML; González Gancedo P; Martínez-Piñeiro JA; de La Peña JJ
Eur Urol; 2000 Mar; 37(3):289-96. PubMed ID: 10720854
[TBL] [Abstract][Full Text] [Related]
15. Power-free chip enzyme immunoassay for detection of prostate specific antigen (PSA) in serum.
Adel Ahmed H; Azzazy HM
Biosens Bioelectron; 2013 Nov; 49():478-84. PubMed ID: 23811482
[TBL] [Abstract][Full Text] [Related]
16. Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.
Steuber T; Nurmikko P; Haese A; Pettersson K; Graefen M; Hammerer P; Huland H; Lilja H
J Urol; 2002 Nov; 168(5):1917-22. PubMed ID: 12394676
[TBL] [Abstract][Full Text] [Related]
17. The simultaneous detection of free and total prostate antigen in serum samples with high sensitivity and specificity by using the dual-channel surface plasmon resonance.
Jiang Z; Qin Y; Peng Z; Chen S; Chen S; Deng C; Xiang J
Biosens Bioelectron; 2014 Dec; 62():268-73. PubMed ID: 25016334
[TBL] [Abstract][Full Text] [Related]
18. Macrophage inhibitory cytokine 1 biomarker serum immunoassay in combination with PSA is a more specific diagnostic tool for detection of prostate cancer.
Li J; Veltri RW; Yuan Z; Christudass CS; Mandecki W
PLoS One; 2015; 10(4):e0122249. PubMed ID: 25853582
[TBL] [Abstract][Full Text] [Related]
19. Value of free prostate-specific antigen (Hybritech Tandem-R) in symptomatic patients consulting the urologist.
Hofer C; Sauerstein P; Wolter C; Scholz M; Hartung R; Breul J
Urol Int; 2000; 64(1):18-23. PubMed ID: 10782027
[TBL] [Abstract][Full Text] [Related]
20. Direct sensing of cancer biomarkers in clinical samples with a designed nanopore.
Lin Y; Ying YL; Shi X; Liu SC; Long YT
Chem Commun (Camb); 2017 Oct; 53(84):11564-11567. PubMed ID: 28990601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
